LEG & GEN GRP P/S (OTCMKTS:LGGNY) Rating Lowered to Sell at Zacks Investment Research

Share on StockTwits

Zacks Investment Research lowered shares of LEG & GEN GRP P/S (OTCMKTS:LGGNY) from a hold rating to a sell rating in a report published on Thursday, Zacks.com reports.

According to Zacks, “LEGAL & GENERAL is a leading UK risk, savings and investment group. Legal & General today provides life assurance and other financial protection products, annuities and long-term savings products including ISA’s and pensions. With over £250 billion in funds under management, it is also the largest investor for UK pension funds. Legal & General has over 5.5 million UK customers. Their products are sold through over thirty bank and building society relationships, through Independent Financial Advisers and also directly to customers. Legal & General Assurance Society Limited, their principal operating company, is one of Europe’s top rated life companies for financial strength, with an AA+ rating from Standard & Poor’s and Aa1 from Moody’s. “

Separately, ValuEngine downgraded LEG & GEN GRP P/S from a hold rating to a sell rating in a research note on Thursday, August 1st.

LGGNY stock opened at $13.83 on Thursday. The stock’s 50 day simple moving average is $16.23 and its 200 day simple moving average is $17.42. LEG & GEN GRP P/S has a fifty-two week low of $13.41 and a fifty-two week high of $19.25. The company has a debt-to-equity ratio of 0.57, a quick ratio of 3.56 and a current ratio of 3.56. The company has a market cap of $16.51 billion, a P/E ratio of 7.28 and a beta of 1.32.


Legal & General Group Plc provides various insurance products and services worldwide. It operates in Legal & General Retirement (LGR), Legal & General Investment Management (LGIM), Legal & General Capital (LGC), Legal & General Insurance (LGI), and General Insurance (GI) segments.

Featured Article: What is an SEC Filing?

Get a free copy of the Zacks research report on LEG & GEN GRP P/S (LGGNY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for LEG & GEN GRP P/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LEG & GEN GRP P/S and related companies with MarketBeat.com's FREE daily email newsletter.